Advanced Medical Solutions Group plc

AMS.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap£423,534£449,068£560,766£728,988
- Cash£17,039£60,160£82,262£72,965
+ Debt£86,564£9,137£9,750£9,860
Enterprise Value£493,059£398,045£488,254£665,883
Revenue£177,521£126,210£124,330£108,601
% Growth40.7%1.5%14.5%
Gross Profit£82,769£70,140£68,621£56,115
% Margin46.6%55.6%55.2%51.7%
EBITDA£29,682£31,398£34,939£31,549
% Margin16.7%24.9%28.1%29.1%
Net Income£7,094£15,889£20,406£17,481
% Margin4%12.6%16.4%16.1%
EPS Diluted0.0330.0730.0930.08
% Growth-55.2%-22%16.1%
Operating Cash Flow£16,729£12,345£27,080£30,409
Capital Expenditures-£4,057-£9,849-£9,964-£6,463
Free Cash Flow£12,672£2,496£17,116£23,946
Advanced Medical Solutions Group plc (AMS.L) Financial Statements & Key Stats | AlphaPilot